MORE►
de-extinction
Beth Shapiro, Ph.D., chief science officer at Colossal Biosciences [Photo: Business Wire]
Colossal Announces $7.5M in New Investments in Ancient DNA Academic Research
by Lance Murray | Apr 17, 2024
Colossal Biosciences’ academic investments include partnerships with Stockholm University, the University of Potsdam, the University of California Santa Cruz, the University of Alaska, McMaster University, University of Copenhagen, and Rowan University, among others.
by Lance Murray |
Mar 19, 2024
Dallas-based Colossal said that in her new role, MacArthur Award winner Beth Shapiro will oversee continued expansion of the company's de-extinction and conservation science teams. The company previously announced plans to "de-extinct" the woolly mammoth, the Tasmanian tiger, and the dodo bird.
MORE►
by Lance Murray |
Feb 21, 2024
Colossal Biosciences and production partner Teton Ridge Entertainment have signed with James Reed, director of the Oscar-winning Netflix documentary "My Octopus Teacher," and his company Underdog Films, to produce the docuseries.
MORE►
by Lance Murray |
Feb 2, 2024
Veteran marketing executive Emily Castel has joined Colossal Bioscience, the world’s first de-extinction company, as its first chief marketing officer, bringing her global entertainment and consumer brand experience to Colossal where she will lead global efforts to scale the company’s brand, experiences, consumer products, and emerging media properties....
MORE►
The African elephant. [Image: Colossal Biosciences]
Colossal Biosciences, Vertebrate Genomes Project Publish First High-Quality Reference Genome of African Elephant
by Lance Murray | May 19, 2023
Last year, the partnership announced a near complete sequence of the Asian elephant genome. Colossal and VGP said the sequencing work is part of a long-term effort to ensure the survival of elephant species in the face of climate change, deforestation, and disease.
MORE►
by Kevin Cummings |
Sep 27, 2022
Dallas-based Colossal Biosciences, the de-extinction company behind plans to bring back the woolly mammoth and thylacine, developed its own software solution "after reviewing everything available on the market." Now it's sharing the platform with the launch of Form Bio.
The spinout's technology tools can help drive the “entire molecular revolution” that is occurring in the life sciences and biotech space, in addition to bolstering the Lone Star state as a hub for the industry, says Chief Strategy Officer Claire Aldridge.
The spinout's technology tools can help drive the “entire molecular revolution” that is occurring in the life sciences and biotech space, in addition to bolstering the Lone Star state as a hub for the industry, says Chief Strategy Officer Claire Aldridge.
MORE►
by David Seeley |
Aug 16, 2022
Colossal is already working to "de-extinct" the woolly mammoth via a mammoth-elephant hybrid project. Now the Tasmanian tiger—which went extinct nearly 100 years ago due to human hunting—is the second species Colossal is seeking to bring back.
"We’re thrilled to be collaborating with Andrew Pask and the University of Melbourne to restore this amazing animal to Earth," said Ben Lamm, Colossal's co-founder and CEO.
MORE►
